GlassScriptPhysician profile
Shirley Ju
NPI 1720442437
$2,207.81
in general payments reported to CMS, 2019-2025
20 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.44 · 2021: $24.67 · 2022: $1,607 · 2023: $371 · 2024: $26.00 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.63 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,001.37 | 2021-2023 | |
| Biogen, INC. | $191.82 | 2022-2025 | Tysabri |
| Neurelis, INC. | $164.41 | 2022 | |
| Lilly USA, LLC | $113.38 | 2022-2024 | Amyvid, Emgality, Reyvow |
| Biohaven Pharmaceutical Holding Company LTD. | $89.57 | 2022 | |
| Amgen INC. | $83.24 | 2022 | |
| Neurocrine Biosciences, INC. | $75.15 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $70.47 | 2022 | |
| Alexion Pharmaceuticals, INC. | $66.20 | 2022 | |
| Celgene Corporation | $63.14 | 2022 | |
| Sk Life Science, INC. | $57.30 | 2022 | |
| Novartis Pharmaceuticals Corporation | $54.08 | 2022 | |
| Argenx US, INC. | $49.31 | 2022 | |
| Amneal Pharmaceuticals LLC | $34.28 | 2022 | |
| Genzyme Corporation | $23.52 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $18.09 | 2022 | |
| Pfizer INC. | $15.77 | 2023 | |
| Kyowa Kirin, INC. | $12.79 | 2022 | |
| Lundbeck LLC | $12.41 | 2022 | |
| Allergan, INC. | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirley Ju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.